Does interleukin-18 play a role in the pathogenesis of hepatic encephalopathy?

Hepato-Gastroenterology

Volumn 58, Issue 106, 2011, Pages 497-502

  Onal, Ibrahim Koral ^a   Akdogan, Meral ^a   Oztas, Erkin ^a   Balci, Mustafa ^b   Kurt, Mevlut ^a   Kacar, Sabite ^a   Kuran, Sedef Ozdal ^a   Karabiber, Nihal ^b   Sasmaz, Nurgul ^b  

^a Turkiye Yuksek Ihtisas Teaching and Research Hospital   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

Cytokines; Inflammation; Liver failure

Indexed keywords

ALBUMIN; BILIRUBIN; C REACTIVE PROTEIN; CREATININE; INTERLEUKIN 18; UREA;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; INFORMATION PROCESSING; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UREA BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; C-REACTIVE PROTEIN; CHRONIC DISEASE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; INTERLEUKIN-18; LIVER DISEASES; MALE; MIDDLE AGED;

EID: 79958097047     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Fantuzzi G, Dinarello CA: Interleukin-18 and interleukin-1 beta: Two cytokine substrates for ICE (caspase-1). J Clin Immunol 1999; 19:1-11. (Pubitemid 29113328)
2. Okamura H, Nagata K, Komatsu T, Tanimoto T, Nukata Y, Tanabe F, Akita K, Torigoe K, Okura T, Fukuda S, et al: A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect Immun 1995; 63:3966-3972.
3. Stoll S, Jonuleit H, Schmitt E, Müller G, Yamauchi H, Kurimoto M, Knop J, Enk AH: Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol 1998; 28:3231-3239.
4. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K: IL-12 up-regulates IL-18 receptor expression on T ceUs, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 1998; 161:3400-3407.
5. Micallef MJ, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M, Tanimoto T, Torigoe K, Fujii M, Ikeda M, Fukuda S, Kurimoto M: Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol 1996; 26:1647-1651. (Pubitemid 26230016)
6. Dao T, Mehal WZ, Crispe IN: IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J Immunol 1998; 161:2217-2222. (Pubitemid 28397032)
7. Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, Ikeda M, Kurimoto M: IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 1997; 158:1541-1550. (Pubitemid 127469506)
8. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, Hartley SB, Menon S, Kastelein R, Bazan F, O'Garra A: IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 1997; 7:571-581. (Pubitemid 27508708)
9. Puren AJ, Razeghi P, Fantuzzi G, Dinarello CA: Interleukin-18 enhances lipopolysaccharide-induced interferon-gamma production in human whole blood cultures. J Infect Dis 1998; 178:1830-1834. (Pubitemid 28558165)
10. Olee T, Hashimoto S, Quach J, Lotz M: IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J Immunol 1999; 162:1096-1100. (Pubitemid 29035439)
11. Gammal SH, Jenes EA: Hepatic encephalopathy. Med Clin North Am 1989; 73:793-813. (Pubitemid 19163725)
12. Blei AT, Cordoba J: Hepatic encephalopathy. Am J Gastroenterol 2001; 96:1968-1976. (Pubitemid 32660887)
13. Shawcross DL, Davies NA, Williams R, Jalan R: Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 2004; 40:247-254. (Pubitemid 38115829)
14. Odeh M, Sabo E, Srugo I, Oliven A: Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure. Liver Int 2004; 24:110-116. (Pubitemid 38584996)
15. Odeh M, Sabo E, Srugo I, Oliven A: Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure. Ann Med. 2005; 37:603-612. (Pubitemid 41780148)
16. Jalan R, O Damink SW, Deutz NE, Lee A, Hayes PC: Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 1999; 354:1164-1168.
17. Clemmesen JO, Hansen BA, Larsen FS: Indomethacin normalizes intracranial pressure in acute liver failure: a twenty-three-year-old woman treated with indomethacin. Hepatology 1997; 26:1423-1425. (Pubitemid 27520006)
18. Jalan R, Kapoor D: Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid. Clin Sci (Lond) 2004; 106:467-474. (Pubitemid 38639550)
19. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT: Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th world congress of gastroenterology, Vienna, 1998. Hepatology 2002; 35:716-721.
20. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D: Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002; 35:357-366. (Pubitemid 34106375)
21. Tsutsui H, Matsui K, Okamura H, Nakanishi K: Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev 2000; 174:192-209. (Pubitemid 30201389)
22. Yamano T, Higashi T, Nouso K, Nakatsukasa H, Kariyama K, Yumoto E, Kobayashi Y, Yamamoto K, Iwagaki H, Yagi T, Tanimoto T, Kurimoto M, Tanaka N, Tsuji T: Serum interferongamma-inducing factor/IL-18 levels in primary biliary cirrhosis. Clin Exp Immunol 2000; 122:227-231.
23. McGuinness PH, Painter D, Davies S, McCaughan GW: Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 2000; 46:260-269.
24. Finotto S, Siebler J, Hausding M, Schipp M, Wirtz S, Klein S, Protschka M, Doganci A, Lehr HA, Trautwein C, Khosravi-Far R, Strand D, Lohse A, Galle PR, Blessing M, Neurath MF: Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut 2004; 53:392-400. (Pubitemid 38241337)
25. Ludwiczek O, Kaser A, Novick D, Dinarello CA, Rubinstein M, Vogel W, Tilg H: Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease. J Clin Immunol 2002; 22:331-337. (Pubitemid 35305882)
26. Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V: Inflammation and hepatic encephalopathy: Ibuprofen restores learning ability in rats with portacaval shunts. Hepatology 2007; 46:514-519. (Pubitemid 47344787)
27. Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Urios A, Rodrigo JM, Felipo V: IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol 2009; 43:272-279.
28. Wong D, Dorovini-Zis K, Vincent SR: Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Exp Neurol 2004; 190:446-455. (Pubitemid 39504999)
29. Shinoda M, Wakabayashi G, Shimazu M, Saito H, Hoshino K, Tanabe M, Morikawa Y, Endo S, Ishii H, Kitajima M: Increased serum and hepatic tissue levels of interleukin-18 in patients with fulminant hepatic failure. J Gastroenterol Hepatol 2006; 21:1731-1736. (Pubitemid 44410887)
30. Roth GA, Faybik P, Hetz H, Hacker S, Ankersmit HJ, Bacher A, Thalhammer T, Krenn CG: Pro-inflammatory interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment. Dig Liver Dis 2009; 41:417-423.
31. Elgouhari HM, O'Shea R: What is the utility of measuring the serum ammonia level in patients with altered mental status? Cleve Clin J Med 2009; 76:252-254.